Phylogica patent allowed
Thursday, 29 September, 2005
Perth-based Phylogica (ASX:PYC) has received formal notice of allowance from the European Patent and Trademark Office for its pending patent application entitled: "Isolating biological modulators from biodiverse gene fragment libraries".
The application was filed in 2000 and protects Phylogica's core peptide library technology. Phylogica's proprietary libraries contain millions of phylomers - stable fragments of naturally occurring proteins.
"Not only are the methods for creating these libraries covered but this foundation patent application also describes methods for increasing the diversity of the libraries further," said Phylogica's scientific director Dr Paul Watt in a statement.
Phylogica has eight patent families and cases from the patent family of this recently allowed application have already been granted in Australia and allowed in the US.
The University of Sydney formalises cervical cancer elimination partnership
The success of a cervical cancer elimination program has led to the signing of a memorandum of...
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
